Member of Parliament from Nellore, Vemireddy Prabhakar Reddy, has said that grit, determination and perseverance give the power to overcome any form of disability. Addressing a public meeting ...

Preceeded by a rich history, small format art of varied styles encapsulating contemporary narratives are on display as part of Vast Meditations, at Apparao Galleries ...

AstaGuru’s upcoming ‘Masters Legacy’ Modern Indian Art Auction will showcase a diverse range of unique and important creations from different phases of India's most celebrated modernists.

Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 95,474.79 Crore) operating in Pharmaceuticals sector. Dr. Reddy's Laboratories Ltd. key ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Reddy’s Laboratories, through one of its subsidiaries, signed commercialisation and license agreements for BAT2206, a proposed biosimilar of Johnson & Johnson’s Stelara and BAT2506 ...

J.C. Escarra is a Major League Baseball player. Escarra, 29, is a career minor leaguer who called his mother March 22 after he found out he had made the New York Yankees roster as a backup catcher ...

TAMPA, Fla. — Sure, J.C. Escarra had doubts of ever making it to the majors. Toiling in independent leagues, driving for Uber and substitute-teaching to supplement a meager income, Escarra ...

Reddy’s Laboratories had a return on equity of 17.87% and a net margin of 17.25%. On average, research analysts expect that Dr. Reddy’s Laboratories Limited will post 0.8 EPS for the current year.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.